Journal article · 2018
Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial
Advances in Chronic Kidney Disease, 25(3), 261–266 · Published 1 May 2018 · DOI 10.1053/j.ackd.2018.02.011
In brief
“Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial” is a 2018 journal article by Martha Rodríguez‐Morán and 3 co-authors, published in Advances in Chronic Kidney Disease. OpenAlex counts 46 citations as of 15 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 46
- Most cited in
- 2021 (8)
- Field-weighted impact
- 3.41
- References
- 29
- Authors
- 4
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Rodríguez‐Morán, M., Simental‐Mendía, L. E., Gamboa‐Gómez, C. I., & Guerrero‐Romero, F. (2018). Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Advances in Chronic Kidney Disease, 25(3), 261–266. https://doi.org/10.1053/j.ackd.2018.02.011
MLA 9
Rodríguez‐Morán, Martha, et al. “Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.” Advances in Chronic Kidney Disease, vol. 25, no. 3, 2018, pp. 261–266. https://doi.org/10.1053/j.ackd.2018.02.011.
Chicago
Rodríguez‐Morán, Martha, Luis E. Simental‐Mendía, Claudia I. Gamboa‐Gómez, and Fernando Guerrero‐Romero. 2018. “Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.” Advances in Chronic Kidney Disease 25 (3): 261–266. https://doi.org/10.1053/j.ackd.2018.02.011.
Harvard
Rodríguez‐Morán, M. et al. (2018) ‘Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial’, Advances in Chronic Kidney Disease, 25(3), pp. 261–266. doi:10.1053/j.ackd.2018.02.011.
IEEE
M. Rodríguez‐Morán, L. E. Simental‐Mendía, C. I. Gamboa‐Gómez, and F. Guerrero‐Romero, “Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial,” Advances in Chronic Kidney Disease, vol. 25, no. 3, pp. 261–266, 2018, doi: 10.1053/j.ackd.2018.02.011.
BibTeX
@article{rodriguezmoran2018oral,
title = {{Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial}},
author = {Rodríguez‐Morán, Martha and Simental‐Mendía, Luis E. and Gamboa‐Gómez, Claudia I. and Guerrero‐Romero, Fernando},
journal = {Advances in Chronic Kidney Disease},
year = {2018},
volume = {25},
number = {3},
pages = {261--266},
doi = {10.1053/j.ackd.2018.02.011},
url = {https://doi.org/10.1053/j.ackd.2018.02.011}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2019 | 1 | |
| 2020 | 7 | |
| 2021 | 8 | |
| 2022 | 6 | |
| 2023 | 5 | |
| 2024 | 3 | |
| 2025 | 8 | |
| 2026 | 7 |
Its field-weighted citation impact is 3.41: it has been cited 3.41 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Nursing › Nutrition and Dietetics › Magnesium in Health and Disease
- magnesium supplementation
- metabolic syndrome
- hypomagnesemia
- magnesium chloride
- blood pressure
- hypertriglyceridemia
- hyperglycemia
- HDL cholesterol
Work with this paper
Most-cited papers in Nursing
- Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled StudyÖmer Toprak, Hüseyin Kurt, Yasin Sarı and 3 more · Kidney & Blood Pressure Research · 2017 · 29,772 citations
- The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm InfantsElda Dermyshi, Yizhong Wang, Chongbing Yan and 4 more · Neonatology · 2017 · 24,587 citations
- Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.Donald E. Paglia, William N. Valentine · PubMed · 1967 · 10,901 citations
- Maternal and child undernutrition and overweight in low-income and middle-income countriesRobert E. Black, Cesar Gomes Victora, Susan P. Walker and 8 more · The Lancet · 2013 · 9,505 citations
- The content validity index: Are you sure you know what's being reported? critique and recommendationsDenise F. Polit, Cheryl Tatano Beck · Research in Nursing & Health · 2006 · 8,193 citations
Questions about this paper
How do I cite this paper in APA style?
Rodríguez‐Morán, M., Simental‐Mendía, L. E., Gamboa‐Gómez, C. I., & Guerrero‐Romero, F. (2018). Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Advances in Chronic Kidney Disease, 25(3), 261–266. https://doi.org/10.1053/j.ackd.2018.02.011
How many times has this paper been cited?
46 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Martha Rodríguez‐Morán, Luis E. Simental‐Mendía, Claudia I. Gamboa‐Gómez, Fernando Guerrero‐Romero.
What is the DOI of this paper?
10.1053/j.ackd.2018.02.011. The permanent link is https://doi.org/10.1053/j.ackd.2018.02.011.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.